Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Nat Genet. 2011 Sep 4;43(10):964-968. doi: 10.1038/ng.936.
Prior studies have identified recurrent oncogenic mutations in colorectal adenocarcinoma and have surveyed exons of protein-coding genes for mutations in 11 affected individuals. Here we report whole-genome sequencing from nine individuals with colorectal cancer, including primary colorectal tumors and matched adjacent non-tumor tissues, at an average of 30.7× and 31.9× coverage, respectively. We identify an average of 75 somatic rearrangements per tumor, including complex networks of translocations between pairs of chromosomes. Eleven rearrangements encode predicted in-frame fusion proteins, including a fusion of VTI1A and TCF7L2 found in 3 out of 97 colorectal cancers. Although TCF7L2 encodes TCF4, which cooperates with β-catenin in colorectal carcinogenesis, the fusion lacks the TCF4 β-catenin-binding domain. We found a colorectal carcinoma cell line harboring the fusion gene to be dependent on VTI1A-TCF7L2 for anchorage-independent growth using RNA interference-mediated knockdown. This study shows previously unidentified levels of genomic rearrangements in colorectal carcinoma that can lead to essential gene fusions and other oncogenic events.
先前的研究已经确定了结直肠腺癌中的复发性致癌突变,并对 11 名受影响个体的蛋白质编码基因外显子中的突变进行了调查。在这里,我们报告了来自 9 名结直肠癌患者的全基因组测序结果,包括原发性结直肠肿瘤和匹配的相邻非肿瘤组织,平均覆盖度分别为 30.7×和 31.9×。我们发现每个肿瘤平均有 75 个体细胞重排,包括两对染色体之间复杂的易位网络。11 个重排编码预测的框内融合蛋白,包括在 97 例结直肠癌中的 3 例中发现的 VTI1A 和 TCF7L2 的融合。尽管 TCF7L2 编码与β-连环蛋白在结直肠癌发生中合作的 TCF4,但融合缺乏 TCF4 β-连环蛋白结合域。我们发现含有融合基因的结直肠癌细胞系在使用 RNA 干扰介导的敲低时依赖于 VTI1A-TCF7L2 进行锚定非依赖性生长。这项研究表明,结直肠癌中存在以前未识别的基因组重排水平,这些重排可导致关键基因融合和其他致癌事件。